Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Fusi

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Cancer Biology & Therapy|September 22, 2010
Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabineZhian Liu, Alberto Fusi, Alexander Schmittel, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 21, 2011
In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotypeBirgit Hotz, Ulrich Keilholz, Alberto Fusi, et al.
Journal of Translational Medicine|March 22, 2012
Expression of chemokine receptors on circulating tumor cells in patients with solid tumorsAlberto Fusi, Zhian Liu, Verena Kümmerlen, et al.
Head & Neck|January 15, 2014
PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxelKatharina Pfisterer, Alberto Fusi, Konrad Klinghammer, et al.
Targeted Oncology|May 15, 2014
Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathwayAlexander Gross, Annett Niemetz-Rahn, Anika Nonnenmacher, et al.
Melanoma Management|September 8, 2018
The role of chemotherapy in the modern management of melanomaRebecca Jane Lee, Noor Ul-Ain-Tariq, Alberto Fusi, et al.
Journal of Translational Medicine|May 21, 2011
Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patientsZhian Liu, Alberto Fusi, Eva Klopocki, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapyAngus G Dalgleish, Silvana Di Palma, Kannon Nathan, et al.
The Journal of Investigative Dermatology|October 1, 2010
Expression of the stem cell markers nestin and CD133 on circulating melanoma cellsAlberto Fusi, Uta Reichelt, Antonia Busse, et al.
The Lancet. Oncology|October 5, 2015
PD-L1 expression as a potential predictive biomarkerAlberto Fusi, Lucia Festino, Gerado Botti, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Cancer Biology & Therapy|September 22, 2010
Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabineZhian Liu, Alberto Fusi, Alexander Schmittel, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 21, 2011
In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotypeBirgit Hotz, Ulrich Keilholz, Alberto Fusi, et al.
Journal of Translational Medicine|March 22, 2012
Expression of chemokine receptors on circulating tumor cells in patients with solid tumorsAlberto Fusi, Zhian Liu, Verena Kümmerlen, et al.
Head & Neck|January 15, 2014
PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxelKatharina Pfisterer, Alberto Fusi, Konrad Klinghammer, et al.
Targeted Oncology|May 15, 2014
Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathwayAlexander Gross, Annett Niemetz-Rahn, Anika Nonnenmacher, et al.
Melanoma Management|September 8, 2018
The role of chemotherapy in the modern management of melanomaRebecca Jane Lee, Noor Ul-Ain-Tariq, Alberto Fusi, et al.
Journal of Translational Medicine|May 21, 2011
Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patientsZhian Liu, Alberto Fusi, Eva Klopocki, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2019
The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapyAngus G Dalgleish, Silvana Di Palma, Kannon Nathan, et al.
The Journal of Investigative Dermatology|October 1, 2010
Expression of the stem cell markers nestin and CD133 on circulating melanoma cellsAlberto Fusi, Uta Reichelt, Antonia Busse, et al.
The Lancet. Oncology|October 5, 2015
PD-L1 expression as a potential predictive biomarkerAlberto Fusi, Lucia Festino, Gerado Botti, et al.
Pageof 5